A SUB-STUDY TO EXPLORE THE BIOMARCATORS OF PHYSICAL FUNCTION IN A CLINICAL PHASE III TEST, RANDOMIZED, CONTROLLED WITH PLACEBO TO EVALUATE THE SAFETY AND EFFECTIVENESS OF ODANACATIB (MK-0822) IN THE REDUCTION OF RISK OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN TREATED WITH VITAMIN D AND CALCIUM.

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2009
This article has no abstract
Epistemonikos ID: a69b95edd8ef57cf63008585a7c075ccc9cd1219
First added on: Apr 16, 2025